Wound is circumscribed injury caused by an external force, which involves injury to any tissue or organ. Surgical wound closure aims to move close the skin flaps to favor rapid healing and a good cosmetic outcome with low risk of complications. On the basis of severity of injury, wounds are classified into acute and chronic wounds. Wounds imposes significant impact on the health of patients, which leads to pain, loss of function and mobility, depression, anxiety, and stress.
The global wound closure market is estimated to be valued at US$ 1.84 billion in 2022 and is expected to exhibit a CAGR of 7.1% during the forecast period (2022-2030).
Figure 1.Global Wound Closure Market Share (%), by Product Type, 2022
Increasing prevalence of diabetes and diabetes associated ulcers are expected to drive growth of the wound closure market
Diabetes foot ulcer is major cause of disability, morbidity and mortality among diabetes patients. For instance, according to an article published by ScienceDirect in December 2021, Diabetic foot ulcer (DFU) and chronic kidney disease (CKD) are two significant complications of diabetes mellitus (DM). According to the same source, up to 19% to 34% of patients with diabetes mellitus will suffer from DFU during their lifetimes. The increased rate of diabetes and associated diabetes foot ulcers are expected to drive the growth of the wound closure market over the forecast period. For instance, according to the data provided by the American Diabetes Association, in February 2022, 37.3 million Americans, or 11.3% of the population, had diabetes in the year 2019.
|Base Year:||2021||Market Size in 2022:||US$ 1.84 Bn|
|Historical Data for:||2017 to 2020||Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||7.1%||2030 Value Projection:||US$ 3.17 Bn|
3M, Smith & Nephew plc, Johnson & Johnson, B. Braun Melsungen AG, Convatec Group PLC, Integra LifeSciences, Medtronic, Mölnlycke Health Care AB, Cardinal Health, and Stryker
|Restraints & Challenges:||
Figure 2.Global Wound Closure Market Share (%), by Region, 2022
Introduction of new advanced technology in wound closure treatment are expected to drive the market growth during the forecast period
Market players operating in wound closure market are focusing on innovation and new launches of wound closure devices to tap emerging market. For instance, in November 2020, Healthium Medtech, one of the largest medical device companies in India, announced the launch of its latest innovation Trubarb, a knotless tissue closure device designed to redefine the suturing experience for surgeons. The device comes with barbs and an effective triangular end stopper that eliminates the need for knotting when compared to a regular suture and eliminates the difficulties of looping when compared to other knotless sutures. It has been designed to shorten suturing time, decrease morbidity and ischemic necrosis that arise due to knotting and simplify the overall suturing experience for surgeons.
Global Wound Closure Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
The COVID-19 pandemic had a negative impact on the wound closure market, due to the decrease in the number of patient visits to hospitals as a result of precautionary measure to protect them from the COVID-19 infection. For instance, according to an article published by the American Journal of Managed Care journal in September 2021, in the early lockdown stage of the pandemic, most outpatient wound care clinics suspended their operations. Even as lockdowns eased and outpatient appointments resumed, many patients avoided appointments out of fear of exposure to COVID-19. Moreover, majority of practices reported a decrease in current patient visits as compared to prepandemic numbers. About 57% of respondents said that wound severity had significantly increased since the start of the pandemic.
Global Wound Closure Market: Key Developments
In June 22, 2022, Advanced Medical Solutions Group plc, a U.K.-based developer and manufacturer of world-leading advanced wound care and wound closure products, received the U.S. Food and Drug Administration 510(k) approval for LiquiBand XL, a new device that can close longer wounds than existing LiquiBand products. The device consists of a surgical mesh which is used to close the wound and LiquiBand glue which is used to strengthen the closure and prevent infection.
In March 2021, KitoTech Medical, a medical device company, announces the addition of a product ‘microMend Combo Pack’ to its growing line of consumer products. This product gives consumers more options to treat wounds and expands the use of microMend to close smaller lacerations and serious cuts on the fingers and discrete areas of the face.
Global Wound Closure Market: Restraint
The major factors that hinder growth of the global wound closure market include infections caused due to wound closure devices and product recalls. For instance, in October 2019, the U.S. Food and Drug Administration (FDA) announced that Ethicon, a subsidiary of Johnson & Johnson, initiated a recall of several lots of its ECHELON FLEX ENDOPATH Staplers. The recall was prompted by the manufacturer discovering that some of the surgical staplers distributed may have an out-of-specification part which could lead to malformed staples
Major players operating in the global wound closure market include 3M, Smith & Nephew plc, Johnson & Johnson, B. Braun Melsungen AG, Convatec Group PLC, Integra LifeSciences, Medtronic, Mölnlycke Health Care AB, Cardinal Health, and Stryker.
Wound closure is the final step of surgical intervention. The primary function in the wound treatment is characterized by wound closure procedure. Surgical wounds can be left to heal by themselves (secondary intention healing) or they can be closed surgically. Surgical wound closure is preferred over the secondary intention in cases to speed up the wound closure and to protect the underlying tissue. Wound closure techniques have evolved significantly and now range from simple sutures to adhesive compounds, and techniques have also improved. Multiple techniques can be used for wound closure. These include sutures, staples, and adhesives. In primary wound closure, sutures are the standard of care. There are two types of sutures, absorbable and non-absorbable. Non-absorbable sutures are preferred because they provide great tensile strength, and the body’s chemicals will not dissolve them during the natural healing process. Non-absorbable sutures are used primarily to close superficial wounds; whereas, absorbable sutures can be placed in a double layer closure for deeper wounds.
The increasing efforts by the key players in the market to advance wound care research is expected to drive the market growth over the forecast period. For instance, in September 2021, HMP Global, an omnichannel leader in healthcare events and education announced details of the new ‘SAWC Change’ campaign, part of the Symposium on Advanced Wound Care (SAWC Fall) that took place as an in-person gathering from October 29 to October 31, 2021, in Las Vegas. The company entered into a partnership with the Wound Healing Foundation (WHF) and debra of America, a non-profit organization, as part of SAWC Change Campaign to advance innovative wound care research and outcomes for patients who suffer with chronic wounds.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.